Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on March 2, 2016, primarily detailing amendments to its By-Laws to implement stockholder proxy access. This change allows eligible stockholders, individually or in groups, who meet specific ownership and holding period requirements, to nominate directors for inclusion in the company's proxy materials. Specifically, a beneficial owner or a group of up to 20 stockholders holding at least 3% of outstanding common stock for a minimum of three continuous years can nominate director candidates. This proxy access provision enables these qualifying stockholders to nominate director nominees representing up to the greater of two directors or 20% of the Board of Directors. The By-Laws also include related conforming revisions to accommodate this new proxy access provision. This move is significant as it shifts certain governance control towards long-term shareholders, potentially increasing accountability and responsiveness to shareholder interests.
Key Highlights
- 1Quest Diagnostics amended its By-Laws, effective February 25, 2016, to adopt a proxy access bylaw.
- 2The new proxy access provision allows eligible stockholders to nominate directors for inclusion in the company's proxy materials.
- 3Eligibility requires owning 3% or more of outstanding common stock continuously for at least 3 years.
- 4A single stockholder or a group of up to 20 eligible stockholders can utilize the proxy access provision.
- 5The provision permits nomination of director candidates constituting up to the greater of 2 directors or 20% of the Board.
- 6Conforming revisions were made to other sections of the By-Laws to support proxy access.
- 7The amended By-Laws were filed as Exhibit 3.1 to the 8-K.